XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Investments:    
Fixed maturities, available for sale, at fair value (net of allowance for credit losses: September 30, 2023 - $69.4 and December 31, 2022 - $56.0; amortized cost: September 30, 2023 - $23,899.5 and December 31, 2022 - $23,384.2) $ 20,305.2 $ 20,353.4
Equity securities at fair value 95.5 135.3
Mortgage loans (net of allowance for credit losses: September 30, 2023 - $10.9 and December 31, 2022 - $8.0) 1,971.3 1,411.9
Policy loans 126.4 121.6
Trading securities 221.2 207.9
Investments held by variable interest entities (net of allowance for credit losses: September 30, 2023 - $2.9 and December 31, 2022 - $5.5; amortized cost: September 30, 2023 - $880.6 and December 31, 2022 - $1,134.2) 858.1 1,077.6
Other invested assets 1,119.9 1,034.7
Total investments 24,697.6 24,342.4
Cash and cash equivalents - unrestricted 460.8 575.7
Cash and cash equivalents held by variable interest entities 122.0 69.2
Accrued investment income 252.3 235.6
Present value of future profits 186.2 203.7
Deferred acquisition costs 1,897.5 1,770.9
Reinsurance receivables (net of allowance for credit losses: September 30, 2023 - $3.0 and December 31, 2022 - $2.0) 4,053.2 4,223.4
Market risk benefit asset 89.3 65.3
Income tax assets, net 1,039.8 1,063.4
Assets held in separate accounts 2.9 2.7
Other assets 705.8 580.8
Total assets 33,507.4 33,133.1
Liabilities for insurance products:    
Policyholder account balances 15,481.8 15,234.2
Future policy benefits 10,829.9 11,240.2
Market risk benefit liability 3.1 11.3
Liability for life insurance policy claims 60.8 64.1
Unearned and advanced premiums 221.2 235.0
Liabilities related to separate accounts 2.9 2.7
Other liabilities 869.6 693.9
Investment borrowings 2,089.4 1,639.5
Borrowings related to variable interest entities 918.5 1,104.6
Notes payable – direct corporate obligations 1,140.1 1,138.8
Total liabilities 31,617.3 31,364.3
Commitments and Contingencies
Shareholders' equity:    
Common stock ($0.01 par value, 8,000,000,000 shares authorized, shares issued and outstanding: September 30, 2023 – 112,163,169; December 31, 2022 – 114,343,070) 1.1 1.1
Additional paid-in capital 1,965.3 2,033.8
Accumulated other comprehensive loss (1,956.7) (1,957.3)
Retained earnings 1,880.4 1,691.2
Total shareholders' equity 1,890.1 1,768.8
Total liabilities and shareholders' equity $ 33,507.4 $ 33,133.1